Clinical Applicability of the Specific Risk Score of Dementia in Type 2 Diabetes in the Identification of Patients with Early Cognitive Impairment: Results of the MOPEAD Study in Spain.

Saved in:
Bibliographic Details
Title: Clinical Applicability of the Specific Risk Score of Dementia in Type 2 Diabetes in the Identification of Patients with Early Cognitive Impairment: Results of the MOPEAD Study in Spain.
Authors: Ortiz Zuñiga, Angel Michael1,2 (AUTHOR) a.ortiz@vhebron.net, Simó, Rafael1,2 (AUTHOR) cristina.hernandez@vhir.org, Rodriguez-Gómez, Octavio3 (AUTHOR) orodriguez@fundacioace.org, Hernández, Cristina1,2 (AUTHOR), Rodrigo, Adrian4 (AUTHOR) arodrigo@gmv.com, Jamilis, Laura4 (AUTHOR) ljamilis@gmv.com, Campo, Laura5 (AUTHOR) campo_laura@lilly.com, Alegret, Montserrat3 (AUTHOR) malegret@fundacioace.com, Boada, Merce3,6 (AUTHOR) rafael.simo@vhir.org, Ciudin, Andreea1,2 (AUTHOR) rafael.simo@vhir.org
Source: Journal of Clinical Medicine. Sep2020, Vol. 9 Issue 9, p2726. 1p.
Database: Academic Search Ultimate
Description
ISSN:20770383
DOI:10.3390/jcm9092726